Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol

被引:7
作者
Briers, Pieter-Jan [1 ]
Langlois, Michel R. [1 ,2 ]
机构
[1] AZ St Jan Hosp, Dept Lab Med, Brugge, Belgium
[2] Univ Ghent, Dept Diagnost Sci, Fac Med & Hlth Sci, Ghent, Belgium
关键词
apolipoprotein B; LDL-cholesterol; Friedewald formula; Martin-Hopkins formula; Sampson formula; ATHEROGENIC LIPOPROTEINS; LOWERING THERAPY; DYSLIPIDEMIA; ASSOCIATION; EQUATION;
D O I
10.11613/BM.2022.010704
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Two new formulas, the Martin-Hopkins and the Sampson formula, were recently developed to overcome shortcomings of the Friedewald formula for calculating LDL-cholesterol. We aimed to compare the concordance of the two formulas with apolipoprotein B (apoB), a surrogate marker of the number of LDL particles. Materials and methods: In a study of serum lipid data of 1179 patients who consulted the AZ St-Jan Hospital Bruges for cardiovascular risk assessment, the correlation and concordance of the Friedewald, Martin-Hopkins and Sampson formulas with apoB concentration, measured by immuno-nephelometry, were determined and compared. Results: The Martin-Hopkins formula showed significantly higher correlation coefficient than the Friedewald formula with apoB in the entire dataset and in patients with low LDL-cholesterol < 1.8 mmol/L. Both Martin-Hopkins and Sampson formulas yielded > 70% concordance of LDL-cholesterol with regard to treatment group classification based on population-equivalent thresholds of apoB in hypertriglyceridemic patients (2-4.5 mmol/L), with the highest concordance (75.6%) obtained using Martin-Hopkins formula vs. 60.5% with Friedewald formula. Conclusion: The Martin-Hopkins (and, to a lesser extent, Sampson) formula is more closely associated with the number of LDL particles than Friedewald formula. This, in combination with literature evidence of lesser accuracy of the Friedewald formula, is an argument to switch from Friedewald to a modified, improved formula.
引用
收藏
页数:11
相关论文
共 30 条
  • [1] Low-density lipoprotein cholesterol estimation by a new formula in Indian population
    Anandaraja, S
    Narang, R
    Godeswar, R
    Laksmy, R
    Talwar, KK
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (01) : 117 - 120
  • [2] LDL Cholesterol: 'The Times They Are A-Changin'
    Chapman, M. John
    Giral, Philippe
    Therond, Patrice
    [J]. CLINICAL CHEMISTRY, 2020, 66 (09) : 1136 - 1139
  • [3] Contois JH, 1996, CLIN CHEM, V42, P515
  • [4] Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
    Contois, John H.
    McConnel, Joseph P.
    Sethi, Amar A.
    Csako, Gyorgy
    Devaraj, Sridevi
    Hoefner, Daniel M.
    Warnick, Russell
    [J]. CLINICAL CHEMISTRY, 2009, 55 (03) : 407 - 419
  • [5] de Graaf J, 2015, APOB CLIN CARE, V1st, DOI [10.1007/978-90-368-0980, DOI 10.1007/978-90-368-0980]
  • [6] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
    Ference, Brian A.
    Ginsberg, Henry N.
    Graham, Ian
    Ray, Kausik K.
    Packard, Chris J.
    Bruckert, Eric
    Hegele, Robert A.
    Krauss, Ronald M.
    Raal, Frederick J.
    Schunkert, Heribert
    Watts, Gerald F.
    Boren, Jan
    Fazio, Sergio
    Horton, Jay D.
    Masana, Luis
    Nicholls, Stephen J.
    Nordestgaard, Borge G.
    van de Sluis, Bart
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Landmesser, Ulf
    Laufs, Ulrich
    Wiklund, Olov
    Stock, Jane K.
    Chapman, M. John
    Catapano, Alberico L.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (32) : 2459 - 2472
  • [7] Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
    Fulcher, Jordan
    O'Connell, Rachel
    Voysey, Merryn
    Emberson, Jonathan
    Blackwell, Lisa
    Mihaylova, Borislava
    Simes, John
    Collins, Rory
    Kirby, Adrienne
    Colhoun, Helen
    Braunwald, Eugene
    La Rosa, John
    Pedersen, T. R.
    Tonkin, Andrew
    Davis, Barry
    Sleight, Peter
    Franzosi, Maria Grazia
    Baigent, Colin
    Keech, Anthony
    de Lemos, J.
    Blazing, M.
    Murphy, S.
    Downs, J. R.
    Gotto, A.
    Clearfield, M.
    Holdaas, H.
    Gordon, D.
    Koren, M.
    Dahloef, B.
    Poulter, N.
    Sever, P.
    Knopp, R. H.
    Fellstroem, B.
    Holdaas, H.
    Jardine, A.
    Schmieder, R.
    Zannad, F.
    Goldbourt, U.
    Kaplinsky, E.
    Colhoun, H. M.
    Betteridge, D. J.
    Durrington, P. N.
    Hitman, G. A.
    Fuller, J.
    Neil, A.
    Wanner, C.
    Krane, V.
    Sacks, F.
    Moye, L.
    Pfeffer, M.
    [J]. LANCET, 2015, 385 (9976) : 1397 - 1405
  • [8] Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003
  • [9] Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL
    Hattori, Y
    Suzuki, M
    Tsushima, M
    Yoshida, M
    Tokunaga, Y
    Wang, Y
    Zhao, D
    Takeuchi, M
    Hara, Y
    Ryomoto, KI
    Ikebuchi, M
    Kishioka, H
    Mannami, T
    Baba, S
    Harano, Y
    [J]. ATHEROSCLEROSIS, 1998, 138 (02) : 289 - 299
  • [10] The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
    Hegele, Robert A.
    Ginsberg, Henry N.
    Chapman, M. John
    Nordestgaard, Borge G.
    Kuivenhoven, Jan Albert
    Averna, Maurizio
    Boren, Jan
    Bruckert, Eric
    Catapano, Alberico L.
    Descamps, Olivier S.
    Hovingh, G. Kees
    Humphries, Steve E.
    Kovanen, Petri T.
    Masana, Luis
    Pajukanta, Paivi
    Parhofer, Klaus G.
    Raal, Frederick J.
    Ray, Kausik K.
    Santos, Raul D.
    Stalenhoef, Anton F. H.
    Stroes, Erik
    Taskinen, Marja-Riitta
    Tybjrg-Hansen, Anne
    Watts, Gerald F.
    Wiklund, Olov
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (08) : 655 - 666